Special Issue "New Update on the Diagnosis and Treatment of Hepatobiliary Cancer"
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Gastroenterology & Hepatopancreatobiliary Medicine".
Deadline for manuscript submissions: closed (30 October 2023) | Viewed by 1753
Special Issue Editors
Interests: hepatobiliary cancer; immune checkpoint inhibitors; surgery; translational research
Interests: hepatobiliary cancer; immune checkpoint inhibitors; surgery; translational research
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Hepatobiliary cancer is a malignant tumor with a high mortality rate among the affected patients. The aggressive behavior of the disease and the typically advanced stage of the disease at the time of diagnosis are the main causes of this high mortality rate. However, in recent years, several advances have been made in the management of this family of diseases. The improvement of surgical techniques, targeted chemotherapy, radiotherapy, immune checkpoint inhibitor therapy, and radiological and endoscopic techniques are at the core of research in the hepatobiliary field.
We invite authors to share their knowledge, perspectives, and recent advances in the management of hepatobiliary malignancies through this Special Issue of the Journal of Clinical Medicine.
Prof. Dr. Weixing Wang
Dr. Jun He
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- liver cancer
- biliary tract cancer
- diagnosis
- treatment
- surgery
- immune checkpoint inhibitors
- translational research
